ODM-203 是一种口服有效的，具有选择性的 FGFR/VEGFR 抑制剂，其对 FGFR3/1/2 和 VEGFR3/2/1/4 的 IC₅₀ 值分别为 6, 11, 16, 5, 9, 26 和 35 nM。ODM-203 具有很强的抗肿瘤活性，并能激活肿瘤微环境中的免疫反应。

ODM-203 is an orally active and selective FGFR/VEGFR inhibitor with IC 50 values of 6, 11, 16, 5, 9, 26 and 35 nM for FGFR3/1/2 and VEGFR3/2/1/4, respectively. ODM-203 has strong anti-tumour activity and activates immune responses in the tumour microenvironment.

Solid

FGFR1 11 nM (IC50) FGFR2 16 nM (IC50

ODM-203 (eight-dose concentration series up to 3 μM; 96 h) potently inhibits FGFR signaling and proliferation in several FGFR-dependent cell lines.
ODM-203 (eight-dose concentration series up to 3 μM; 10 days) inhibits endothelial tubule formation.
ODM-203 (1, 10, 100, 1000 nM; 1 h) inhibiting FGFR and VEGFR cellular signaling in HUVEC cells. has not independently confirmed the accuracy of these methods. They are for reference only.Cell Viability

ODM-203 (20, 40 mg/kg; p.o.; single daily for 21 days) inhibits FGFR phosphorylation and tumor growth in several FGFR-dependent xenografts by suppressing FGFR signaling in tumors.
ODM-203 (7, 20, 40 mg/kg; p.o.; single daily for 21 days) shows strong anti-tumor activity in a VEGFR-dependent angiogenic orthotopic syngenic model (Renca) and suppresses angiogenesis.
ODM-203 (20, 40 mg/kg; p.o.; single daily for 5 days) activates immune response in the tumor microenvironment. has not independently confirmed the accuracy of these methods. They are for reference only.

Room temperature in continental US; may vary elsewhere.

Powder -20°C 3 years；4°C 2 years

[1]. Holmstr?m TH, et al. ODM-203, a Selective Inhibitor of FGFR and VEGFR, Shows Strong Antitumor Activity, and Induces Antitumor Immunity. Mol Cancer Ther. 2019 Jan;18(1):28-38.

In Vitro: DMSO : 66.67 mg/mL (131.88 mM; Need ultrasonic)配制储备液